Neurology Sterile Injectable Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
Neurology sterile injectables are generally administered to individuals suffering from pain linked to the nerves. Neuropathic pain injections are used to provide relief to these individuals. Neurology sterile injectable block the pain signal from reaching the brain. Neurological sterile injection can be administered at sympathetic nervous system, trigger points, dorsal roots, and peripheral nerves. The most commonly use neurological injectable used for nerve block are steroid injection, opioids, and local anesthetics. Neurology sterile injectables are prescribed to individuals suffering from disc hernia.
Neurology sterile injectable are used to treat dystonia, a disorder described as involuntary sustained muscle contractions due to twisting and abnormal postures. In order to treat the disorder therapeutic botulinum toxin is used which has a high success rate. The botulinum toxin was first introduced in 1980’s. In 2000, the FDA approved Myobloc, for the treatment of cervical dystonia to reduce abnormality of head position and pain associated with cervical dystonia. Dysport was approved in 2009 for the treatment is generally carried out for a period of 3-4 months. It has to be noticed that administration of these therapies require a thorough understanding regarding the use of the substance and practical knowledge about dosages. Other medical condition where Botox is used includes blepharospasm (uncontrolled spasm of the eyelid), overactive bladder and incontinence caused due to multiple sclerosis or any spinal cord injury and chronic migraine among adults.
Neurology sterile injectable are also used to treat occipital neuralgia, which occurs when the optical nerve is injured or inflamed, this neurological condition is sometimes diagnosed as migraine. Major symptoms of optical neuralgia are severe pain at the back of the neck and head, tenderness in posterior scalp, and pain caused by neck movement. Occipital neuralgia is caused due to compression of the optic nerve. The compression can be due to trauma, osteoarthritis, tumor in neck, and cervical disc disease. Treatment of optical neuralgia is carried out by injecting a combination of anesthetic and steroid, which is administered near the nerve.
Rising prevalence of neurological disease, increase in research activities and product development, growing awareness in developing countries, increase in health care infrastructure are factors that are expected to drive the global neurology sterile injectable market during the forecast period. However, stringent regulations regarding product approval and high operational costs are likely to restrain the neurology sterile injectable market during the forecast period.
The neurology sterile injectable market is segment based on drug type, disease indication, distribution channel, and geography. In terms of drug type, the global neurology sterile injectable market is divided into opioids, steroids, anesthetics, and others. Based on disease indication, the neurology sterile injectable market is categorized into dystonia, blepharospasm, optical neuralgia, and others. In terms of distribution channel, the global neurology sterile injectable market is segregated into hospital pharmacies, drug stores, and e-commerce.
The global neurology sterile injectable market is divided into five regions namely; North America, Europe, Asia Pacific, Latina America, and Middle East & Africa. North America is expected to hold a major share of the neurology sterile injectable market as compared to other regions due to presence of major pharmaceutical manufacturers, favorable reimbursement policies, and large patient pool. Europe is expected to be the second largest neurology sterile injectable market during the forecast period. The neurology sterile injectable market in Asia Pacific is anticipated to expand at high growth rate during the forecast period due to changing demographics, increase in participation from local manufacturers, and rise in health care infrastructure in developing economies such as India. Latin America and Middle East & are expected to create lucrative opportunity during the forecast period due to increasing participation from governments and rising presence of major manufacturers in neurology sterile injectable regions.
Major companies operating in the global neurology sterile injectable market are Merck & Co., F-Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, and other prominent players.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017